Novel mHealth Trial Uses Smartphone GPS to Predict Bipolar Episodes in Veterans — Early Warning System Could Transform Care
247 Health News Editorial
·27 Apr 2026
·4 min read
·clinical-trialsThe MEASURE-BD trial is pioneering smartphone GPS tracking to predict bipolar episodes in Veterans days before they occur. This innovative mHealth approach could transform bipolar care by providing early warning systems that don't rely on patient self-reporting.
Originally reported by ClinicalTrials.gov
References
- 1.VA Office of Research and Development. (2024). mHealth Estimate-based Algorithms Signaling Upcoming Recurrence of Episodes in Bipolar Disorders (MEASURE-BD). ClinicalTrials.gov. https://clinicaltrials.gov/study/NCT06204705
- 2.Faurholt-Jepsen, M., Frost, M., Ritz, C., Christensen, E. M., Jacoby, A. S., Mikkelsen, R. L., Bardram, J., Vinberg, M., & Kessing, L. V. (2020). Daily electronic self-monitoring in bipolar disorder using smartphones - the MONARCA I trial: a randomized, placebo-controlled, single-blind, parallel group trial. Psychological Medicine, 50(5), 838-848. https://doi.org/10.1017/S0033291719000710
- 3.Gershon, A., & Eidelman, P. (2015). Inter-episode sleep and circadian rhythm disturbances in bipolar disorder. Current Psychiatry Reports, 17(10), 80. https://doi.org/10.1007/s11920-015-0617-9
- 4.Hidalgo-Mazzei, D., Mateu, A., Reinares, M., Matic, A., Vieta, E., & Colom, F. (2016). Smartphone apps for bipolar disorder: a systematic review of features and content quality. Journal of Medical Internet Research, 18(12), e318. https://doi.org/10.2196/jmir.5943
- 5.Merikangas, K. R., Jin, R., He, J. P., Kessler, R. C., Lee, S., Sampson, N. A., Vidal-Ribas, P., Georgiades, K., Lim, C. C., Gluzman, S., Navarro-Mateu, F., Pennell, B. E., Piazza, M., Posada-Villa, J., Sasu, C., Torres, Y., & Zarkov, Z. (2011). Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Archives of General Psychiatry, 68(3), 241-251. https://doi.org/10.1001/archgenpsychiatry.2011.12
- 6.Goodwin, G. M., Haddad, P. M., Ferrier, I. N., Aronson, J. K., Barnes, T., Cipriani, A., Coghill, D. R., Fazel, S., Geddes, J. R., Grunze, H., Holmes, E. A., Howes, O., Hudson, S., Hunt, N., Jones, I., Macmillan, I. C., McAllister-Williams, H., Miklowitz, D. R., Morriss, R., Munafò, M., Paton, C., Saharkian, B. J., Saunders, K., Sinclair, J., Taylor, D., Vieta, E., & Young, A. H. (2016). Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology. Journal of Psychopharmacology, 30(6), 495-553. https://doi.org/10.1177/0269881116636545
2
247 Health News Editorial
247 Health News is a medical intelligence platform delivering evidence-based research appraisals, clinical trial monitoring, and health technology news for healthcare professionals.
Related Articles
clinical-trials
Digital Health Platform vs Case Manager Support in Hypertension Management: Taiwan's 1,726-Participant Trial Signals a Shift in Blood Pressure Care Delivery
3 Aug 2026
clinical-trials
Phase II Trial: AI-Powered Wysa Chatbot vs Unmet Need — Digital Eating Disorder Prevention in At-Risk Adolescents
3 Aug 2026
clinical-trials
Pilot Trial Targets the Inpatient-to-Outpatient Gap: Digital Smoking Cessation Intervention for Persons With Serious Mental Illness — Key Findings for Clinicians
3 Aug 2026
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service